Melanoma

	07/08/2009	Emerging Strategies for the Treatment of Metastatic Melanoma: The Role of Monoclonal Antibodies in Targeted Immunotherapy
	10/14/2008	Moving Beyond Standard Therapy in Malignant Melanoma: Novel Agents and Combinations
	08/08/2008	Adjuvant Interferon Therapy Prolongs Relapse-Free Interval and Survival in Melanoma
	08/08/2008	Rational Vaccine Strategies May Better Harness the Immune System for Anticancer Response in Melanoma
	08/08/2008	Response May Not Be an Appropriate Endpoint for Evaluating Benefit From CTLA-4 Antagonists in Melanoma
	07/30/2008	Limitations of Current Systemic Treatments for Melanoma Highlight the Need for Novel Drugs
	07/30/2008	Assessing Clinical Benefit From CTLA-4 Antagonists in the Treatment of Melanoma
	07/30/2008	Do Toxicities Associated With CTLA-4 Antagonists Always Correlate With Response in the Treatment of Melanoma?